1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide

C24H37F3N4O2 — CID 171493775

IUPAC1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide
SMILESCCCCCN(CCC)C(=O)C1CCCCCN(C2CCc3c2n[nH]c(=O)c3C(F)(F)F)C1
InChIInChI=1S/C24H37F3N4O2/c1-3-5-8-14-30(13-4-2)23(33)17-10-7-6-9-15-31(16-17)19-12-11-18-20(24(25,26)27)22(32)29-28-21(18)19/h17,19H,3-16H2,1-2H3,(H,29,32)
InChIKeyNGXRHHKPQFEVEG-UHFFFAOYSA-N
MW470.58 g/mol
LogP4.70
Rot. Bonds8

About 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide

1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide (PubChem CID 171493775) has the molecular formula C24H37F3N4O2 and a molecular weight of 470.58 g/mol. Its IUPAC name is 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide.

Molecular Properties

Compound Name1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide
PubChem CID171493775
Molecular FormulaC24H37F3N4O2
Molecular Weight470.58 g/mol
Exact Mass470.29
IUPAC Name1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide
SMILESCCCCCN(CCC)C(=O)C1CCCCCN(C2CCc3c2n[nH]c(=O)c3C(F)(F)F)C1
InChIInChI=1S/C24H37F3N4O2/c1-3-5-8-14-30(13-4-2)23(33)17-10-7-6-9-15-31(16-17)19-12-11-18-20(24(25,26)27)22(32)29-28-21(18)19/h17,19H,3-16H2,1-2H3,(H,29,32)
InChIKeyNGXRHHKPQFEVEG-UHFFFAOYSA-N
XLogP4.70
TPSA69.30 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500470.58
LogP ≤ 54.70
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide?
The IUPAC name of 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide (CID 171493775) is 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide.
What is the SMILES notation for 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide?
The canonical SMILES for 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide is CCCCCN(CCC)C(=O)C1CCCCCN(C2CCc3c2n[nH]c(=O)c3C(F)(F)F)C1.
What is the InChIKey of 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide?
The InChIKey is NGXRHHKPQFEVEG-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H37F3N4O2/c1-3-5-8-14-30(13-4-2)23(33)17-10-7-6-9-15-31(16-17)19-12-11-18-20(24(25,26)27)22(32)29-28-21(18)19/h17,19H,3-16H2,1-2H3,(H,29,32).
What are the key properties of 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide?
1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide has a molecular weight of 470.58 g/mol, XLogP of 4.70, 8 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-oxo-4-(trifluoromethyl)-2,5,6,7-tetrahydrocyclopenta[c]pyridazin-7-yl]-N-pentyl-N-propylazocane-3-carboxamide is sourced from PubChem (CID 171493775), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).